Sophie Bouchat
Gosselies, WAL 6041, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Novel role of UHRF1 in the epigenetic repression of the latent HIV-1.
Journal: EBioMedicine
Published: September 02, 2021
Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: February 16, 2019
The Molecular Biology of HIV Latency.
Journal: Advances in experimental medicine and biology
Published: July 22, 2018
Molecular Control of HIV and SIV Latency.
Journal: Current topics in microbiology and immunology
Published: October 27, 2017
Immunity drives TET1 regulation in cancer through NF-κB.
Journal: Science advances
Published: October 13, 2017
On the way to find a cure: Purging latent HIV-1 reservoirs.
Journal: Biochemical pharmacology
Published: May 04, 2017
Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir.
Journal: AIDS (London, England)
Published: October 19, 2016
Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.
Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.
Journal: Scientific reports
Published: September 20, 2016
Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites.
Journal: Scientific reports
Published: August 01, 2016
Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.
Journal: EMBO molecular medicine
Published: December 19, 2015
Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.
Journal: Scientific reports
Published: October 09, 2015
Last Updated: 09/26/2026